Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Decoding movement intent of patient with multiple sclerosis for the powered lower extremity exoskeleton.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.
Effect of light finger touch in balance control of individuals with multiple sclerosis.
Effects of a virtual reality and treadmill training on gait of subjects with multiple sclerosis: a pilot study.
Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire.
Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Epistatic effects on the phenotype of multiple sclerosis.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Multiple sclerosis in children.
Pages
« first
‹ previous
…
536
537
538
539
540
541
542
543
544
…
next ›
last »